LeállítvaNo phase
A Long-term Follow-up Study of Patients Who Received VOR33
Megadott ok: Lack of Funding
Key facts
- Where
- Bethesda, Cleveland, Hackensack, La Jolla, Miami, New York, Seattle és St Louis, Egyesült ÁllamokSee the 10 sites
Where in Egyesült Államok
- National Institutes of Health Clinical CenterBethesda, Egyesült ÁllamokNo longer taking part
- University Hospitals Seidman Cancer CenterCleveland, Egyesült ÁllamokNo longer taking part
- John Theurer Cancer Center at Hackensack University Medical CenterHackensack, Egyesült ÁllamokNo longer taking part
- University of California San Diego Moores Cancer CenterLa Jolla, Egyesült ÁllamokNo longer taking part
- Miami Cancer InstituteMiami, Egyesült ÁllamokNo longer taking part
- Columbia University Medical Center - Herbert Irving Comprehensive Cancer CenterNew York, Egyesült ÁllamokNo longer taking part
- Icahn School of Medicine at Mount SinaiNew York, Egyesült ÁllamokNo longer taking part
- Memorial Sloan-Kettering Cancer CenterNew York, Egyesült ÁllamokNo longer taking part
- Fred Hutchinson Cancer Research CenterSeattle, Egyesült ÁllamokNo longer taking part
- Washington University School of Medicine - Siteman Cancer CenterSt Louis, Egyesült ÁllamokNo longer taking part
Trial details
- Who runs it
- Vor Biopharma
- Trial code
- NCT05309733
- Record updated
- 2025. július 29.
- Original description
VOR33 long-term follow-up (LTFU) studyRead full original descriptionShow less
VOR33 long-term follow-up (LTFU) study
Inclusion: A patient is included in this study if he/she:; Has received any part of or all of a VOR33 infusion.
Exclusion: There are no exclusion criteria.